• FAQs
  • Glossary
Close

FAQs

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

See full Glossary

Case Studies

This section contains case studies on ATMP development. Follow the links below to learn about the development processes, the keys to success, the challenges and how developers overcame them: 

Case study: Holoclar

learn about the development of Holoclar, a Tissue Engineered Product (TEP)
Go to case study

Case Study: Strimvelis

learn about the development of Strimvelis, a Gene Therapy Medicinal Product (GTMP)
Go to case study

Case Study: Therapy Classification

Early therapy classification considerations in developing skin equivalents
Go to case study

  

Back to Research Pathways

Back to top
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts